Predictors of the Ability to Protect the Airway in Long-term Ventilated Patients

Sponsor
Massachusetts General Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT01618240
Collaborator
(none)
30
1
15
2

Study Details

Study Description

Brief Summary

First part of a 2 part study with the same IRB protocol #, and labeled 'A'. Investigators hypothesized that clinical muscle strength assessment (manual muscle testing) predicts the ability to protect the airway during swallowing in long-term ventilated subjects. More specifically, the investigators hypothesized that low muscle strength is associated with the inability to clear secretions from the peri-laryngeal area (valleculae and pyriform sinus residue scale (VPSR scale [NRS: 0-4] of > 1) and entering the materials into airway (PAS scale [1-8]> 1), which should predispose to endotracheal aspiration.

Condition or Disease Intervention/Treatment Phase
  • Other: Muscle Strength Measurement
  • Other: Ventilator

Study Design

Study Type:
Observational
Actual Enrollment :
30 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Determining Predictors of Adequate Upper Airway Function in Long-term Ventilated Patients
Study Start Date :
Jan 1, 2011
Actual Primary Completion Date :
Apr 1, 2012
Actual Study Completion Date :
Apr 1, 2012

Arms and Interventions

Arm Intervention/Treatment
Long term ventilated subjects

Muscle Strength Measurement, ventilator

Other: Muscle Strength Measurement
MRC score (0-60) is a clinical assessment of muscle power on abduction of the arm, flexion of the forearm, extension of the wrist, flexion of the leg, extension of the knee and dorsal flexion of the foot with the score of (0-5) on each measurement

Other: Ventilator
A mechanical ventilator is used to assist or replace spontaneous breathing.

Outcome Measures

Primary Outcome Measures

  1. Muscle Strength [Within 24 hours of fiberoptic endoscopic evaluation of swallow]

    We use Medical Research Council (MRC) scale (0-60) to evaluate the degree of muscle weakness in the tracheostomized patients.

Secondary Outcome Measures

  1. Number of Patients With Muscle Weakness (MRC<48) Who Developed Clinical Aspiration [Within 3 month follow-up]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Patients admitted to the Respiratory Acute Care Unit and Surgical Intensive Care Unit, units with a mixed collection of long term ventilated patients in a major academic teaching hospital.

  2. Age over 18 years.

  3. Long-term ventilated patients (>10 days) with tracheotomies

Exclusion Criteria:
  1. Decreased level of consciousness as defined by a Richmond Agitation Sedation Scale (RASS) of 0.

  2. Non-cooperative patient, CAM score positive for delirium.

  3. For women: pregnancy.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Massachusetts general Hospital Boston Massachusetts United States 02114

Sponsors and Collaborators

  • Massachusetts General Hospital

Investigators

  • Principal Investigator: Matthias Eikermann, MD, PhD, MGH, Harvard Medical School

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Matthias Eikermann, Assistant Professor, Massachusetts General Hospital
ClinicalTrials.gov Identifier:
NCT01618240
Other Study ID Numbers:
  • 2010P001919A
First Posted:
Jun 13, 2012
Last Update Posted:
Oct 13, 2014
Last Verified:
May 1, 2013
Keywords provided by Matthias Eikermann, Assistant Professor, Massachusetts General Hospital
Additional relevant MeSH terms:

Study Results

Participant Flow

Recruitment Details
Pre-assignment Detail
Arm/Group Title Long-term Ventilated Subjects
Arm/Group Description Long-term (>10 days hours) ventilated subjects were included.
Period Title: Overall Study
STARTED 30
COMPLETED 30
NOT COMPLETED 0

Baseline Characteristics

Arm/Group Title Baseline Population
Arm/Group Description Thirty long-term ventilated patients admitted in two intensive care units at Massachusetts General Hospital.
Overall Participants 30
Age (Count of Participants)
<=18 years
0
0%
Between 18 and 65 years
23
76.7%
>=65 years
7
23.3%
Age (years) [Mean (Standard Deviation) ]
Mean (Standard Deviation) [years]
55
(14)
Sex: Female, Male (Count of Participants)
Female
14
46.7%
Male
16
53.3%
Region of Enrollment (participants) [Number]
United States
30
100%

Outcome Measures

1. Primary Outcome
Title Muscle Strength
Description We use Medical Research Council (MRC) scale (0-60) to evaluate the degree of muscle weakness in the tracheostomized patients.
Time Frame Within 24 hours of fiberoptic endoscopic evaluation of swallow

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Muscle Strength Measurement
Arm/Group Description Muscle Strength Measurement : MRC score (0-60) is a clinical assessment of muscle power on abduction of the arm, flexion of the forearm, extension of the wrist, flexion of the leg, extension of the knee and dorsal flexion of the foot with the score of (0-5) on each measurement
Measure Participants 30
Clinically significant muscle weakness (<48)
20
66.7%
No clinically significant muscle weakness (>=48)
10
33.3%
2. Secondary Outcome
Title Number of Patients With Muscle Weakness (MRC<48) Who Developed Clinical Aspiration
Description
Time Frame Within 3 month follow-up

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Muscle Strength Measurement
Arm/Group Description Muscle Strength Measurement : MRC score (0-60) is a clinical assessment of muscle power on abduction of the arm, flexion of the forearm, extension of the wrist, flexion of the leg, extension of the knee and dorsal flexion of the foot with the score of (0-5) on each measurement
Measure Participants 20
Symptomatic aspiration
14
46.7%
No symptomatic aspiration
6
20%

Adverse Events

Time Frame
Adverse Event Reporting Description
Arm/Group Title Long-term Ventilated Subjects
Arm/Group Description 30 consented long-term ventilated patients
All Cause Mortality
Long-term Ventilated Subjects
Affected / at Risk (%) # Events
Total / (NaN)
Serious Adverse Events
Long-term Ventilated Subjects
Affected / at Risk (%) # Events
Total 0/30 (0%)
Other (Not Including Serious) Adverse Events
Long-term Ventilated Subjects
Affected / at Risk (%) # Events
Total 0/30 (0%)

Limitations/Caveats

[Not Specified]

More Information

Certain Agreements

All Principal Investigators ARE employed by the organization sponsoring the study.

There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.

Results Point of Contact

Name/Title Hooman Mirzakhani
Organization Massachusetts General Hospital
Phone 617-291-9779
Email hmirzakhani@partners.org
Responsible Party:
Matthias Eikermann, Assistant Professor, Massachusetts General Hospital
ClinicalTrials.gov Identifier:
NCT01618240
Other Study ID Numbers:
  • 2010P001919A
First Posted:
Jun 13, 2012
Last Update Posted:
Oct 13, 2014
Last Verified:
May 1, 2013